Jagsonpal Pharmaceuticals Share Price Today | Stock Price & Jagsonpal Pharmaceuticals Share Screener

Track the current stock price of Jagsonpal Pharmaceuticals with an interactive chart. Analyse JAGSNPHARM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Jagsonpal Pharmaceuticals stock quote in one place.

The quote of ₹229.47 sits between the 52-week low of ₹161.07 and the 52-week high of ₹243.97, and the latest session moved -0.98% from the previous close.

Screen Jagsonpal Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for JAGSNPHARM shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE048B01035.

Classification

Identifiers and Leadership

Screen JAGSNPHARM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹317, up from ₹278 in 2025.

Latest statistics put total assets at ₹317 and shareholder funds at ₹276, with a leverage ratio of 0.03.

Screen Jagsonpal Pharmaceuticals income statement and profit fundamentals. Analyze JAGSNPHARM quarterly results. Jagsonpal Pharmaceuticals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹306 and net profit was ₹46, equal to earnings per unit of ₹6.80, at an operating margin of 20%.

In that period expenses were ₹235, interest cost ₹1 and tax ₹14. The next period listed, 2026-March, shows revenue of ₹299 and net profit of ₹43.

Screen JAGSNPHARM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹47, and net cash flow was an outflow of ₹1.

Over the same period, investing activities used ₹36 and financing activities used ₹12.

See Jagsonpal Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check Jagsonpal Pharmaceuticals promoter holding and ownership changes for JAGSNPHARM on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 67.89%, foreign institutions 2.44%, domestic institutions 0.22% and the public 20.73%, spread across 26,264 shareholders.

The shareholder count was 26,264 in 2026-Mar, compared with 24,824 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Jagsonpal Pharmaceuticals. Jagsonpal Pharmaceuticals dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹4.00 per unit for 2026-March, a yield of 1.73%, compared with ₹2.50 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹4.00, ₹2.50 and ₹5.00 per unit.

See which indices include Jagsonpal Pharmaceuticals stock. Check JAGSNPHARM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Jagsonpal Pharmaceuticals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Jagsonpal Pharmaceuticals stock events that may affect JAGSNPHARM share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 18, 2026, with a record date of September 18, 2026.

It is followed by Dividend dated September 4, 2026 and Quarterly Result Announcement dated July 29, 2026.

Screen JAGSNPHARM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen JAGSNPHARM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 4, 2026.

The next most recent announcements are dated October 2, 2026 and October 2, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.